Where Trusted Expertise Meets Real-World Impact

As cancer incidence rises and therapeutic complexity grows, the role of healthcare CFOs and clinicians becomes increasingly central.

As managing the costs of specialty healthcare continues to be a core focus for patients, providers, and payers, transitioning site of care delivery for patients requiring infusion therapy has become a topic of increasing interest.

As access to meaningful healthcare data continues to expand, there is increasing momentum to equip pharmacy HUB services with actionable insights and analytics. These centralized services play a vital role in coordinating patient support, prior authorization, and adherence programs.

Specialty medications now account for over 75% of all drugs in development. These therapies present a forward-thinking approach to treating complex, chronic, and rare diseases, offering hope and potentially life-changing solutions for patients and healthcare providers.

In observance of Rare Disease Month, AscellaHealth shines a light on the stories of patients with rare diseases. We recently interviewed Mario, an inspiring patient dealing with Idiopathic Thrombocytopenia Purpura (ITP), on our podcast, AscellaHealth Podcast Pulse.

Part 2 of this series expands on previous insights, examines value-based care models and associated payment approaches, and highlights real-world examples of payers and manufacturers successfully implementing these innovative, performance-based strategies.